Paratek Pharmaceuticals I... (PRTK)
2.23
0.04 (1.83%)
At close: Sep 20, 2023, 8:00 PM
1.83% (1D)
| Bid | n/a |
| Market Cap | 127.83M |
| Revenue (ttm) | 167.74M |
| Net Income (ttm) | -67.12M |
| EPS (ttm) | -1.11 |
| PE Ratio (ttm) | -2.009009009009009 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 4,476,125 |
| Avg. Volume (20D) | 599,679 |
| Open | 2.19 |
| Previous Close | 2.19 |
| Day's Range | 2.19 - 2.24 |
| 52-Week Range | 1.29 - 3.65 |
| Beta | 1.70 |
About PRTK
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia and acute ...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 3, 2009
Employees 268
Stock Exchange NASDAQ
Ticker Symbol PRTK
Website https://paratekpharma.com